|
|
Exchange: |
|
Security
Type: |
|
Shares
Out: |
10,940,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
|
Level
II Sector: |
|
Level
III Sector: |
|
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile NeuroSense Therapeutics is engaged in the development of therapeutics for neurodegenerative diseases. Co. is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease and Parkinson's disease, among other. Co.'s product candidate, PrimeC, is an extended-release oral formulation of a fixed dose combination of two generic United States Food and Drug Administration - approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Harrison Deborah Marriott |
Member of 13(d) group |
|
2010-05-13 |
4 |
S |
$0.49 |
$3,700 |
I/I |
(7,560) |
97,269 |
|
- |
|
Nachtigal Patricia |
Director and Officer Senior Vi |
|
2010-05-04 |
144 |
NP |
$0.00 |
$2,130,800 |
/ |
56,000 |
0 |
|
- |
|
Ferro Michael W Jr |
Director |
|
2010-04-27 |
4 |
A |
$0.06 |
$627 |
D/D |
10,000 |
10,000 |
|
- |
|
Mjg IV Limited Partnership |
|
|
2010-04-22 |
144 |
NP |
$0.00 |
$1,027,115 |
/ |
19,202 |
0 |
|
- |
|
Gabelli Group Capital Partners Inc |
|
|
2010-04-05 |
144 |
NP |
$0.00 |
$32,040 |
/ |
600 |
0 |
|
- |
|
Amersey Nitin |
CFO |
|
2010-03-17 |
4 |
B |
$9.00 |
$900 |
D/D |
100 |
5,100 |
2.81 |
- |
|
Birshtein Boris |
Chief Executive Officer |
|
2010-03-15 |
4 |
B |
$0.00 |
$1,000 |
I/I |
21,000,000 |
77,922,000 |
2.64 |
- |
|
Burton Eric James |
Director |
|
2010-02-10 |
4 |
A |
$19.94 |
$2,413 |
D/D |
121 |
13,003 |
|
- |
|
Van Patten Robert M. |
CEO and President |
|
2009-12-08 |
4 |
A |
$0.07 |
$700 |
D/D |
10,000 |
46,000 |
|
- |
|
Adkins John Christopher |
SVP & Chief Operating Officer |
|
2009-11-16 |
4 |
S |
$0.78 |
$3,822 |
I/I |
(4,912) |
0 |
|
- |
|
Halftermeyer Daniel A |
Group Vice President |
|
2009-11-11 |
4 |
D |
$5.54 |
$1,939 |
D/D |
(350) |
0 |
|
- |
|
Herbert Tabin |
Former Exec. Ofc. & Director |
|
2009-11-02 |
4 |
S |
$0.00 |
$500 |
D/D |
(225,000,000) |
71,250,000 |
|
- |
|
Everson Scott A |
Sr Vp Chief Operations Officer |
|
2009-10-29 |
4 |
B |
$0.60 |
$782 |
D/D |
1,314 |
41,868 |
2.74 |
- |
|
Kristen Robinson |
VP, Human Resources |
|
2009-09-13 |
4 |
D |
$1.21 |
$1,193 |
D/D |
(987) |
37,546 |
|
- |
|
Landesbank Berlin Ag |
Affiliate through securities o |
|
2009-06-01 |
144 |
NP |
$0.00 |
$1,882,276 |
/ |
192,069 |
0 |
|
- |
|
Landesbank Berlin Ag |
Affiliate through securities o |
|
2009-06-01 |
144 |
NP |
$0.00 |
$1,882,276 |
/ |
192,069 |
0 |
|
- |
|
Pegge Andrew |
DIRECTOR |
|
2009-05-13 |
144 |
NP |
$0.00 |
$6,327,117 |
/ |
105,628 |
0 |
|
- |
|
Pegge Andrew |
DIRECTOR |
|
2009-05-13 |
144 |
NP |
$0.00 |
$6,327,117 |
/ |
105,628 |
0 |
|
- |
|
First Trust Portfolios Lp |
Affiliate of the Issuers Advis |
|
2009-05-05 |
144 |
NP |
$0.00 |
$48,694 |
/ |
5,236 |
0 |
|
- |
|
First Trust Portfolios Lp |
Affiliate of the Issuers Advis |
|
2009-05-05 |
144 |
NP |
$0.00 |
$21,302 |
/ |
5,352 |
0 |
|
- |
|
First Trust Portfolios Lp |
Affiliate of the Issuers Advis |
|
2009-05-05 |
144 |
NP |
$0.00 |
$83,252 |
/ |
5,236 |
0 |
|
- |
|
First Trust Portfolios Lp |
Affiliate of the Issuers Advis |
|
2009-05-05 |
144 |
NP |
$0.00 |
$83,252 |
/ |
5,236 |
0 |
|
- |
|
First Trust Portfolios Lp |
Affiliate of the Issuers Advis |
|
2009-05-05 |
144 |
NP |
$0.00 |
$21,302 |
/ |
5,352 |
0 |
|
- |
|
First Trust Portfolios Lp |
Affiliate of the Issuers Advis |
|
2009-05-05 |
144 |
NP |
$0.00 |
$48,694 |
/ |
5,236 |
0 |
|
- |
|
Irvin Steven D |
Director |
|
2009-04-28 |
|
A |
$83.33 |
$1,000 |
D/D |
12 |
17,413 |
|
- |
|
181 Records found
|
|
Page 2 of 8 |
|
|